Yufeng Ding Selected Research

camrelizumab

1/2021

Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufeng Ding Research Topics

Disease

9	Neoplasms (Cancer) 01/2023 - 04/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 10/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2021
2	Neoplasm Metastasis (Metastasis) 04/2017 - 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Dyskinesias (Dyskinesia) 01/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Deglutition Disorders (Dysphagia) 01/2023
1	Carcinogenesis 01/2023
1	Dystonia (Limb Dystonia) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Adenocarcinoma 01/2022
1	Eructation (Eructations) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Obesity 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Pain (Aches) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Ankylosing Spondylitis 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Psoriatic Arthritis 01/2022
1	Hypokinesia (Bradykinesia) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Bell Palsy (Bell's Palsy) 01/2022
1	Overweight 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Hypoalbuminemia 03/2021
1	Kidney Diseases (Kidney Disease) 03/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Gout 09/2020
1	Hyperuricemia 09/2020
1	Diabetes Mellitus 10/2018
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Hypersensitivity (Allergy) 11/2017

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
3	EnzymesIBA 01/2023 - 10/2021
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 10/2021
2	NivolumabIBA 09/2023 - 01/2022
2	Glutamate DehydrogenaseIBA 01/2023 - 10/2021
2	Glutamic Acid (Glutamate)FDA Link 01/2023 - 10/2021
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2017
2	Amino Acids FDA Link 12/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2021
2	OSM-LIF ReceptorsIBA 01/2022 - 01/2019
2	TensinsIBA 01/2019 - 04/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 04/2017
2	CorticosteroneIBA 11/2017 - 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 12/2023
1	Sorafenib (BAY 43-9006)FDA Link 09/2023
1	Ointments (Pastes)IBA 01/2023
1	Phosphodiesterase 4 InhibitorsIBA 01/2023
1	crisaboroleIBA 01/2023
1	lenvatinibIBA 01/2023
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Leflunomide (Arava)FDA LinkGeneric 01/2023
1	Dihydroorotate DehydrogenaseIBA 01/2023
1	Ceruloplasmin (Ferroxidase)IBA 01/2023
1	CopperIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Karyopherins (Importin)IBA 01/2023
1	Axitinib (AG 013736)IBA 04/2022
1	osimertinibIBA 01/2022
1	olaparibIBA 01/2022
1	secukinumabIBA 01/2022
1	semaglutideIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	PlatinumIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	dacomitinibIBA 10/2021
1	CreatinineIBA 03/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2021
1	camrelizumabIBA 01/2021
1	Xanthine DehydrogenaseIBA 09/2020
1	Uric Acid (Urate)IBA 09/2020
1	FYX-051IBA 09/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	2- (1- hydroxy- 4- oxocyclohexa- 2,5- dienyl)pyran- 4- oneIBA 12/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017
1	Histones (Histone)IBA 04/2017
1	TransferasesIBA 04/2017
1	Histone MethyltransferasesIBA 04/2017
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 01/2017
1	SteroidsIBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	CholesterolIBA 01/2017
1	steroidogenic acute regulatory proteinIBA 01/2017

Therapy/Procedure

6	Therapeutics 12/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2023 - 10/2018
1	Surgical Instruments (Clip) 01/2023
1	Punctures 01/2022